Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice

Fig. 1

Peripheral blood data for patients. a-e The counts of neutrophils, lymphocytes, monocytes, total leukocytes in the blood and serum levels of IL-6 in the HCC (n = 113) and Non-HCC group (n = 59) (3.57 ± 1.38 vs. 2.62 ± 0.93, 109/L, P < 0.001; 1.48 ± 0.52 vs. 1.47 ± 0.54, 109/L, P = 0.926; 0.45 ± 0.16 vs. 0.35 ± 0.13, 109/L, P < 0.001; 5.71 ± 1.67 vs. 4.96 ± 1.20, 109/L, P = 0.003; 8.75 ± 13.13 vs. 2.66 ± 2.36, pg/ml, P = 0.001 respectively) (f) Serum IL-6 level in the histopathologic gradesIgroup (n = 39) and gradesII, III group (n = 74) (14.02 ± 15.95 vs. 5.98 ± 10.46, pg/ml, P = 0.006)

Back to article page